236 related articles for article (PubMed ID: 27895743)
1. Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing.
Kameta E; Sugimori K; Kaneko T; Ishii T; Miwa H; Sato T; Ishii Y; Sue S; Sasaki T; Yamashita Y; Shibata W; Matsumoto N; Maeda S
Oncol Lett; 2016 Nov; 12(5):3875-3881. PubMed ID: 27895743
[TBL] [Abstract][Full Text] [Related]
2. Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.
Habib JR; Zhu Y; Yin L; Javed AA; Ding D; Tenior J; Wright M; Ali SZ; Burkhart RA; Burns W; Wolfgang CL; Shin E; Yu J; He J
J Gastrointest Surg; 2021 Dec; 25(12):3149-3159. PubMed ID: 34244950
[TBL] [Abstract][Full Text] [Related]
3. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
Gan Q; Roy-Chowdhuri S; Duose DY; Stewart JM; Coronel E; Bhutani MS; Lee JH; Weston B; Ge PS; Ross WA; Maitra A
Cancer Cytopathol; 2022 Apr; 130(4):275-283. PubMed ID: 34905283
[TBL] [Abstract][Full Text] [Related]
4. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
5. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis.
Bunduc S; Varzaru B; Iacob RA; Sorop A; Manea I; Spiridon A; Chelaru R; Croitoru AE; Becheanu G; Dumbrava M; Dima S; Popescu I; Gheorghe C
World J Gastroenterol; 2023 May; 29(18):2864-2874. PubMed ID: 37274073
[TBL] [Abstract][Full Text] [Related]
7. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
[TBL] [Abstract][Full Text] [Related]
8. Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should
Béchade D; Palmieri LJ; Bonhomme B; Pernot S; Léna J; Fonck M; Pesqué S; Boillet G; Italiano A; Roseau G
Therap Adv Gastroenterol; 2024; 17():17562848231224943. PubMed ID: 38250014
[TBL] [Abstract][Full Text] [Related]
9. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.
Park JK; Lee JH; Noh DH; Park JK; Lee KT; Lee JK; Lee KH; Jang KT; Cho J
Gut Liver; 2020 May; 14(3):387-394. PubMed ID: 31581388
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study.
Fulmer CG; Park K; Dilcher T; Ho M; Mirabelli S; Alperstein S; Hissong EM; Pittman M; Siddiqui M; Heymann JJ; Yantiss RK; Borczuk AC; Fernandes H; Sigel C; Song W; Mosquera JM; Rao R
Cancer Cytopathol; 2020 Nov; 128(11):840-851. PubMed ID: 32598087
[TBL] [Abstract][Full Text] [Related]
11. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101
[TBL] [Abstract][Full Text] [Related]
12. Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: A retrospective study.
Ishizawa T; Makino N; Matsuda A; Kakizaki Y; Kobayashi T; Ikeda C; Sugahara S; Tsunoda M; Ueno Y
PLoS One; 2020; 15(1):e0228565. PubMed ID: 31999789
[TBL] [Abstract][Full Text] [Related]
14. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma.
Lai JP; Yue Y; Zhang W; Zhou Y; Frishberg D; Jamil LH; Mirocha JM; Guindi M; Balzer B; Bose S; Cao D; Lo S; Fan X; Rutgers JK
Pancreatology; 2017; 17(4):617-622. PubMed ID: 28501471
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.
Bournet B; Selves J; Grand D; Danjoux M; Hanoun N; Cordelier P; Buscail L
J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941
[TBL] [Abstract][Full Text] [Related]
16. Team work and cytopathology molecular diagnosis of solid pancreatic lesions.
Fabbri C; Gibiino G; Fornelli A; Cennamo V; Grifoni D; Visani M; Acquaviva G; Fassan M; Fiorino S; Giovanelli S; Bassi M; Ghersi S; Tallini G; Jovine E; Gasbarrini A; de Biase D
Dig Endosc; 2017 Sep; 29(6):657-666. PubMed ID: 28190274
[TBL] [Abstract][Full Text] [Related]
17. P53 immunolabeling in EUS-FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy.
Oshima M; Okano K; Kamada H; Suto H; Ando Y; Ibuki E; Ishikawa R; Masaki T; Haba R; Suzuki Y
J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):802-814. PubMed ID: 36448271
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma.
Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH
Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas.
Levy MJ; Kipp BR; Milosevic D; Schneider AR; Voss JS; Avula R; Kerr SE; Henry MR; Highsmith E; Liu MC; Gleeson FC
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1632-1640.e1. PubMed ID: 29526691
[TBL] [Abstract][Full Text] [Related]
20. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.
Brand RE; Adai AT; Centeno BA; Lee LS; Rateb G; Vignesh S; Menard C; Wiechowska-Kozłowska A; Bołdys H; Hartleb M; Sanders MK; Munding JB; Tannapfel A; Hahn SA; Stefańczyk L; Tsongalis GJ; Whitcomb DC; Conwell DL; Morisset JA; Gardner TB; Gordon SR; Suriawinata AA; Lloyd MB; Wylie D; Labourier E; Andruss BF; Szafranska-Schwarzbach AE
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1717-23. PubMed ID: 24662333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
